Walsogynes H-O from Walsura chrysogyne.

Eight new limonoids, walsogynes H-O (1-8) were isolated from the barks of Walsura chrysogyne, and their structures were determined on the basis of the 1D and 2D NMR data. Walsogynes H-M (1-6) and O (8) were concluded to be 11,12-seco limonoids with a dodecahydro-1H-naphtho[1,8-bc:3,4-c']difuran skeleton, and walsogyne N (7) to be 11,12-seco limonoid sharing a unique dodecahydronaphtho[1,8-bc:5,4-b'c']difuran skeleton. Walsogynes H-O (1-8) exhibited potent antimalarial activity against Plasmodium falciparum 3D7 strain with IC50 value of 2.5, 2.6, 1.6, 2.5, 1.5, 2.6, 2.1, and 1.1 µM, respectively.

Introduction

Walsura, a genus belonging to Meliaceae, is composed of about 16 species distributed from Sri Lanka to the Himalaya and Indochina through Malaysia, Indonesia to New Guinea, and Walsura chrysogyne is distributed in Peninsular Malaysia [1]. The plants of this genus have been reported to produce limonoids, dammarane, tirucallane and apotirucallane triterpenoids [2-7]. In our search for new bioactive compounds [8-27], we have reported the isolation of new limonoids and triterpenoids from plants of this genus [3, 4, 19], and alkaloids showing antimalarial activity [22, 26, 27]. Continuation of the bioassay-guided investigation on the extract of W. chrysogyne bark led to the isolation of eight new limonoids, walsogynes H–O (1–8) showing antimalarial activity (Fig. 1). Structure elucidation of 1–8 and their antimalarial activity of a series of walsogynes are reported herein.

Fig. 1

Structures of 1–8

Results and discussions

Compounds 1–8 were obtained as optically active white amorphous solids. The 1H and 13C NMR data (Tables 1 and 2) suggested the identity of 1–8 as walsogynes derivatives. Based on the 13C NMR data, 1–6 and 8 were assumed to be derivatives of walsogyne A [2], and 7 was assumed to be a derivative of walsogyne B [4].

Table 1

1H NMR data of 1–8 in CD3OD (* in DMSO-d6)

	1	2	3	4	5
2a	5.91 (1H, d, 9.8)	2.66 (1H, d, 17.5)	5.90 (1H, d, 9.8)	5.97 (1H, d, 9.8)	5.96 (1H, d, 9.7)
2b		3.14 (1H, d, 17.5)
3	7.05 (1H, d, 9.8)	3.58 (1H, brs)	7.05 (1H, d, 9.8)	7.20 (1H, d, 9.8)	7.20 (1H, d, 9.8)
5	3.53 (1H, d, 12.9)	3.00 (1H, d, 12.5)	3.53 (1H, d, 13.0)	2.65 (1H, d, 12.6)	2.65 (1H, d, 12.6)
6	4.38 (1H, dd, 12.9, 3.2)	4.41 (1H, d, 12.5)	4.40 (1H, dd, 13.2, 3.0)	4.46 (1H, dd, 12.6, 2.9)	4.47 (1H, dd, 12.7, 2.7)
7	5.45 (1H, d, 3.2)	5.32 (1H, brs)	5.46 (1H, d, 3.0)	5.37 (1H, d, 3.0)	5.38 (1H, d, 2.9)
9	2.75 (1H, d, 6.7)	2.75 (1H, d, 6.4)	2.76 (1H, d, 6.6)	2.85 (1H, d, 7.1)	2.84 (1H, d, 7.0)
11	5.51 (1H, d, 6.7)	5.24 (1H, d, 6.4)	5.51 (1H, d, 6.6)	5.27 (1H, d, 7.1)	5.25 (1H, d, 7.1)
12	9.67 (1H, s)	9.58 (1H, s)	9.72 (1H, s)	9.58 (1H, s)	9.64 (1H, m)
15	4.31 (1H, d, 4.7)	4.91 (1H, d, 4.5)	4.31 (1H, d, 4.8)	4.91 (1H, m)	4.91 (1H, d, 5.3)
16a	1.77 (1H, m)	1.79 (1H, m)	1.77 (1H, m)	1.82 (1H, m)	1.82 (1H, m)
16b	2.68 (1H, ddd, 16.3, 11.1, 5.3)	2.79 (1H, m)	2.68 (1H, m)	2.78 (1H, ddd, 19.0, 11.0, 5.4)	2.77 (1H, ddd, 15.6, 10.6, 5.1)
17	3.40 (1H, m)	3.48 (1H, m)	3.41 (1H, m)	3.48 (1H, m)	3.47 (1H, m)
18	1.23 (3H, s)	1.22 (3H, s)	1.23 (3H, s)	1.22 (3H, s)	1.23 (3H, m)
19	1.33 (3H, s)	1.43 (3H, s)	1.33 (3H, s)	1.40 (3H, s)	1.38 (3H, m)
21	5.45* (1H, brs)	5.37* (1H, m)	5.34* (1H, m)	5.45* (1H, m)	5.45* (1H, m)
22	6.07* (1H, brs)	6.13* (1H, m)	6.28* (1H, m)	6.25* (1H, m)	6.26* (1H, m)
28a	3.27 (1H, m)	3.44 (1H, d, 7.0)	3.31 (1H, m)	3.30 (1H, d, 7.2)	3.34 (1H, m)
28b	3.60 (1H, d, 6.9)	3.67 (1H, d, 7.0)	3.61 (1H, d, 7.0)	3.67 (1H, d, 7.2)	3.69 (1H, d, 7.3)
29	1.25 (3H, s)	1.32 (3H, s)	1.25 (3H, s)	1.29 (3H, s)	1.29 (3H, m)
30	1.66 (3H, s)	1.64 (3H, s)	1.66 (3H, s)	1.67 (3H, s)	1.67 (3H, m)
3′a	5.61 (1H, qd, 7.1, 1.3	6.79 (1H, q, 6.5)	5.61 (1H, s)	6.72 (1H, q, 6.4)	5.67 (1H, m)
3′b			6.49 (1H, s)		5.92 (1H, m)
4′	1.76 (3H, d, 7.1)	1.84 (3H, d, 6.5)	1.89 (3H, m)	1.81 (3H, d, 6.4)
5′	1.79 (3H, brs)	1.84 (3H, s)		1.82 (3H, s)	1.92 (3H, m)
3-OMe		3.34 (3H, s)

Table 2

13C NMR data of 1–8

	1a	2a	3a	4a	5a	6a	6b	7c	8a
1	205.4	213.7	205.4	202.6	202.5	214.1	212.3	106.7	203.0
2	131.1	40.4	131.1	131.2	131.2	40.2	40.0	37.2	131.0
3	152.8	81.8	152.8	154.6	154.6	81.9	80.6	69.2	155.0
4	42.6	44.5	42.7	42.7	42.7	44.5	43.4	42.5	42.6
5	46.2	42.1	46.3	47.1	47.1	42.0	40.8	40.0	46.9
6	74.7	73.9	74.6	74.4	74.4	74.1	73.0	71.6	74.6
7	73.0	74.1	73.3	73.5	73.8	73.9	72.7	74.4	73.4
8	52.8	56.5	52.8	56.5	56.6	56.7	55.8	43.5	56.8
9	59.2	65.0	59.3	63.6	63.7	64.7	64.2	58.4	63.3
10	46.1	50.3	46.2	46.3	46.3	50.3	49.2	46.8	46.3
11	96.6	99.4	96.6	98.8	98.8	99.1	98.5	106.5	98.5
12	202.6	201.3	203.0	201.6	201.9	202.9	200.9	N.D	203.0
13	59.6	60.2	59.7	60.1	60.2	60.2	59.5	58.5	60.2
14	98.4	100.3	98.5	99.9	100.0	100.7	100.0	72.0	100.0
15	80.7	80.6	80.7	80.8	80.8	80.2	79.6	60.2	80.4
16	40.2	39.4	40.2	39.4	39.5	33.1	33.0	29.5	33.2
17	41.3	41.2	42.1	41.2	41.2	46.8	46.4	N.D	46.8
18	12.7	13.1	12.8	13.1	13.1	14.2	14.3	13.0	14.3
19	22.3	22.3	22.3	22.4	22.4	22.2	21.6	18.3	22.5
20	148.6	148.6	148.6	148.6	148.6	82.6	N.D	148.6	82.5
21	98.9	98.9	98.9	98.9	98.9	109.0	108.4	98.9	109.0
22	120.4	120.4	120.4	120.4	120.4	82.5	81.8	120.4	82.6
23	171.5	171.5	171.5	171.5	171.5	111.7	111.3	171.5	112.0
28	80.7	77.7	80.7	80.4	80.4	77.5	76.4	76.8	80.3
29	20.3	19.3	20.4	20.4	20.5	19.3	18.6	18.9	20.4
30	25.8	24.1	25.8	23.8	23.9	23.6	23.7	23.9	23.4
1′	169.2	168.4	168.6	168.0	167.4	168.4	166.4	164.9	168.0
2′	130.8	130.7	138.8	130.9	138.9	130.8	130.5	128.1	131.0
3′	139.7	139.0	127.2	138.6	125.9	138.3	135.9	137.4	138.0
4′	14.5	12.1	18.4	14.6	18.5	12.1	14.1	14.4	12.3
5′	12.0	14.6		12.3		14.6	14.3	12.3	14.6
3-OMe		58.1				58.1	57.5
11-OMe								56.1
21-OMe						54.3	54.1		54.3
23-OMe						56.4	55.6		56.4

aIn CD3OD; b in C5D5N; cin DMSO-d6

Compounds 1 and 4 were determined to have the same molecular formula, C31H38O11, based on the HR-ESIMS data. Their 1H and 13C NMR data are highly similar and the differences are similar to the differences of walsogynes F and G [4], indicating the structure of 1 as 11-epi-4. Furthermore, except for the signal associated with the α,β-unsaturated-γ-lactone moiety (C-20–C-23), the 1H and 13C NMR data of 4 and walsogyne A were highly similar. Thus, the structures of 1 and 4 were deduced to be as shown in Fig. 1. Analysis of the 2D NMR data further supported the proposed structures.

Compounds 3 and 5 were also determined to possess the same molecular formula, C30H36O11. Furthermore, their NMR data are highly similar to each other and to 1 and 4. However, the signals associated with CH-3′ and CH3-4′ of the tiglate moiety in 1 and 4 are not observed in 3 and 5, and sp2 methylene signals (δC 127.2, δH 5.61 and 6.49, and δC 125.9, δH 5.67 and 5.92 for 3 and 5) are observed instead. Therefore, 3 and 5 should have a methacrylate moiety instead of a tiglate moiety. Analysis of the 2D NMR data supported the structures of 3 and 5 to be as shown in Fig. 1. Specifically, the presence of a methacrylate moiety was supported by the HMBC correlations of H3-4′ to C-1′, C-2′ and C-3′.

Compound 2 was revealed to have the molecular formula C32H42O12 by HRESITOFMS. Its NMR data are highly similar to 4. However, the signals for H-2 and H-3 in 1 are not observed in 2, and a methoxy signal (δH 3.34) and three aliphatic signals (δH 2.66, d, 17.5; δH 3.14, d, 17.5; and δH 3.58, br s) are observed instead. Based on the chemical shifts and the multiplicity patterns, 2 was proposed to be 2,3-dihydro-3α-methoxy-4. The proposed structure was also confirmed through analysis of the 2D NMR data. In particular, the HMBC correlations of H3-29 and the methoxy to C-3, and H-3 to C-1, and the NOESY correlation of H-3/H3-29 confirmed the position and the configuration of the methoxy at C-3.

By HRESITOFMS, 6 and 8 were revealed to have the molecular formula C34H50O14 and C33H46O13, respectively. Their NMR data are also highly similar to 4 and 2, respectively, differing only on the signals assigned to the α,β-unsaturated-γ-lactone in 2 and 4. Analysis of the NMR data revealed that the furan moiety in both 6 and 8 were highly oxidized. The planar structure of the modified furan moiety in 6 was deduced from the 1H-1H COSY correlation of H-22 and H-23, and the HMBC correlations of H-21 to C-17 and C-20, H-22 to C-17, H-23 to C-21, a methoxy (δH 3.07) to C-21 and a methoxy (δH 3.38) to C-23 (Fig. 2). The relative configuration of the furan moiety was then deduced from the ROESY correlations in pyridine-d6 to be as shown in Fig. 3 since only the proposed configuration in Fig. 1 will fulfill the conditions set by the ROESY correlations shown in Fig. 3. Based on the 1H and 13C NMR data of 6 and 8, the furan moiety in 8 should have the same relative configuration as in 6. Thus, the structure of 8 was proposed to be as shown in Fig. 1.

Fig. 2

Selected 2D NMR correlations of 6

Fig. 3

Selected ROESY correlations of 6

Compound 7 was revealed to have the molecular formula C32H42O12 by HRESITOFMS. Its 1H and 13C NMR data are highly similar to walsogyne B. However, the NMR data suggested that the furan moiety in walsogyne B was oxidized to a lactone moiety similar to the one found in 1. Furthermore, the signals for H-2 and H-3 in walsogyne B are also not observed in 7, and three aliphatic signals (δH 1.92, δH 1.98 and δH 3.57) are observed instead. Finally, the HMBC correlations of H3-29 to C-3 and H-3 to C-1 and the NOESY correlation of H-3/H3-29 confirmed the position and the α orientation of the hydroxy at C-3.

Considering that 1–8 were isolated from the same extract as walsogynes B-G [4], their absolute configurations were assumed to be similar to walsogynes B-G based on the biogenetic relationships.

Antimalarial activity

Walsogynes H–O (1–8) were tested for the antimalarial activity against Plasmodium falciparum 3D7 strain. The assay showed that 1–8 had potent in vitro antimalarial activity [the half-maximal (50%) inhibitory concentration (IC50) = 2.5, 2.6, 1.6, 2.5, 1.5, 2.6, 2.1, and 1.1 µM, respectively] (Table 3).

Table 3

Antimalarial activity of 1–8 and walsogynes B, D, and E against Plasmodium falciparum 3D7 strain

IC50 (µM)
1	2.5
2	2.6
3	1.6
4	2.5
5	1.5
6	2.6
7	2.1
8	1.1
Walsogyne B	2.4
Walsogyne D	2.6
Walsogyne E	2.6

From Walsura spp., one of limonoid peroxide has been reported to show antimalarial activity [28]. We also reported some limonoids, ceramicines A–D isolated from the barks of C. ceramicus, exhibited antimalarial activity against P. falciparum 3D7 in vitro [29]. However, the skeleton of these limonoids was different from that of walsogynes. A series of walsogynes H–O (1–8) and walsogynes B, D, and E (IC50 = 2.4, 2.6, and 2.6 µM, respectively) had more potent antimalarial activity than these known limonoids (Table 3). The activity might be depending on their unique 11,12-seco limonoid skeleton but not influenced by their substituent patterns.

Experimental section

General experimental procedures

Optical rotations were measured on a JASCO DIP-1000 polarimeter. UV spectra were recorded on a Shimadzu UVmini-1240 spectrophotometer and IR spectra on a JASCO FT/IR-4100 spectrophotometer. High-resolution ESI MS were obtained on a JMS-T100LP (JEOL). 1H and 2D NMR spectra were measured on a 400 MHz or 600 MHz spectrometer at 300 K, while 13C NMR spectra were on a 100 MHz or 150 MHz spectrometer. The residual solvent peaks were used as internal standards (δH 7.26 and δC 77.0 for CDCl3, δH 3.31 and δC 49.0 for CD3OD).

Material

The barks of W. chrysogyne were collected in Mersing, Malaysia in October 2000. The botanical identification was made by Mr. Teo Leong Eng, Faculty of Science, University of Malaya. Voucher specimens (Herbarium No. 4957) are deposited in the Herbarium of Chemistry Department, University of Malaya.

Extraction and isolation

The dried ground barks of W. chrysogyne (440 g) were extracted successively with MeOH and 54 g of extract were obtained. The total extract was successively partitioned with n-hexane, EtOAc, n-BuOH, and water. The EtOAc-soluble materials (11.5 g) were separated with a silica gel column (CHCl3/MeOH, 1:0 → 0:1) to obtain 10 fractions (E-1 ~ E-10). Fraction E-5 was further separated to five fractions (E-5-1 ~ E-5-5) with an LH-20 column (CHCl3/MeOH, 1:1). Fraction E-5-3 was further separated with a silica gel column (CHCl3/MeOH, 1:0 → 0:1) to obtain 13 fractions (E-5-3-1 ~ E-5-3-13). Fraction E-5-3-9 was further separated by HPLC (Shiseido C18 MGII, H2O/MeCN, 70:30) to obtain impure 1–5. Impure 1 and 3–5 were purified using HPLC (Nacalai tesque Cholester, H2O/MeCN, 80:20) to obtain pure 1 (1.3 mg, 0.0003%, tR 70 min), 3 (1.3 mg, 0.0003%, tR 58 min), 4 (0.5 mg, 0.0001%, tR 46 min) and 5 (1.8 mg, 0.0004%, tR 38 min). In addition, impure 2 was purified using HPLC (Nacalai tesque Cholester, H2O/MeCN, 75:25) to obtain pure 2 (1.8 mg, 0.0004%, tR 48 min). Fraction E-5-3-8 was further separated by HPLC (Shiseido C18 MGII, H2O/MeCN, 70:30) to obtain 6 (1.3 mg, 0.0003%, tR 26 min), 7 (2.4 mg, 0.0005%, tR 20 min), 8 (0.5 mg, 0.0001%, tR 22 min).

Walsogyne H () white amorphous solid. [α]D28 − 28 (c 1.0, MeOH). IR (film) vmax 3411, 2928, 1746, 1710, 1671 cm−1. UV (MeOH) λmax (log ε) 216 (4.32) nm. CD (MeOH) λmax (Δε) 205 (12.50), 228 (− 1.79), 250 (2.29), 300 (− 1.01) nm. ESIMS m/z 609 (M + Na)+. HRESIMS m/z 609.2335 [calcd for C31H38O11Na (M + Na)+: 609.2312].

Walsogyne I () white amorphous solid. [α] D28 − 10 (c 1.0, MeOH). IR (film) vmax 3435, 2928, 1743, 1721, 1711 cm−1. UV (MeOH) λmax (log ε) 213 (4.52) nm. CD (MeOH) λmax (Δε) 206 (4.13), 226 (− 2.08), 247 (1.36), 297 (0.25) nm. ESIMS m/z 641 (M + Na)+. HRESIMS m/z 641.2571 [calcd for C32H42O12Na (M + Na)+: 641.2574].

Walsogyne J () white amorphous solid. [α]D28 − 40 (c 0.41, MeOH). IR (film) vmax 3411, 2920, 1715, 1670 cm−1. UV (MeOH) λmax (log ε) 211 (4.04) nm. CD (MeOH) λmax (Δε) 205 (5.98), 225 (0.67), 243 (− 1.70), 304 (− 0.51) nm. ESIMS m/z 595 (M + Na)+. HRESIMS m/z 595.2160 [calcd for C30H36O11Na (M + Na)+: 595.2155].

Walsogyne K () white amorphous solid. [α] D28 − 12 (c 0.7, MeOH). IR (film) vmax 3444, 2926, 1747, 1714, 1681 cm−1. UV (MeOH) λmax (log ε) 215 (4.09) nm. CD (MeOH) λmax (Δε) 208 (8.78), 228 (− 1.41), 247 (1.77), 296 (− 0.63), 349 (0.29) nm. ESIMS m/z 609 (M + Na)+. HRESIMS m/z 609.2309 [calcd for C31H38O11Na (M + Na)+: 609.2312].

Walsogyne L () white amorphous solid. [α] D28 − 1.5 (c 0.58, MeOH). IR (film) vmax 3418, 2957, 2922, 1715 cm−1. UV (MeOH) λmax (log ε) 209 (4.53) nm. CD (MeOH) λmax (Δε) 208 (4.26), 220 (0.30), 242 (2.30), 297 (− 0.55), 350 (0.29) nm. ESIMS m/z 595 (M + Na)+. HRESIMS m/z 595.2183 [calcd for C30H36O11Na (M + Na)+: 595.2155].

Walsogyne M () white amorphous solid. [α] D18 − 21 (c 0.92, MeOH). IR (film) vmax 3446, 2931, 1731, 1716, 1698 cm−1. UV (MeOH) λmax (log ε) 213 (4.54) nm. CD (MeOH) λmax (Δε) 204 (9.84), 239 (0.038), 296 (0.97) nm. ESIMS m/z 705 (M + Na)+. HRESIMS m/z 705.3121 [calcd for C34H50O14Na (M + Na)+: 705.3109].

Walsogyne N () white amorphous solid. [α] D18 − 14 (c 1.00, MeOH). IR (film) vmax 3393, 2919, 1716 cm−1. UV (MeOH) λmax (log ε) 211 (4.42) nm. CD (MeOH) λmax (Δε) 209 (4.94), 258 (0.78), 304 (− 1.34) nm. ESIMS m/z 619 (M + H)+. HRESIMS m/z 619.2802 [(M + H)+ calcd for C32H43O12 (M + H)+: 619.2755].

Walsogyne O () white amorphous solid. [α] D18 − 32 (c 0.33, MeOH). IR (film) vmax 3401, 2947, 1715, 1652 cm−1. UV (MeOH) λmax (log ε) 216 (4.51) nm. CD (MeOH) λmax (Δε) 210 (15.32), 240 (− 1.04), 287 (− 0.50) nm. ESIMS m/z 673 (M + Na)+. HRESIMS m/z 673.2816 [calcd for C33H46O13Na (M + Na)+: 673.2836].

Parasite strain culture P. falciparum laboratory strain 3D7 was obtained from Prof. Masatsugu Kimura (Osaka City University, Osaka, Japan). For the assessment of antimalarial activity of the compounds in vitro, the parasites were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 0.5 g/L l-glutamine, 5.96 g/L HEPES, 2 g/L sodium bicarbonate (NaHCO3), 50 mg/L hypoxanthine, 10 mg/L gentamicin, 10% heat-inactivated human serum, and red blood cells (RBCs) at a 3% hematocrit in an atmosphere of 5% CO2, 5% O2, and 90% N2 at 37 °C as previously described [30]. Ring-form parasites were collected using the sorbitol synchronization technique [31]. Briefly, the cultured parasites were collected by centrifugation at 840 g for 5 min at room temperature, suspended in a fivefold volume of 5% d-sorbitol (Nacalai Tesque, Kyoto, Japan) for 10 min at room temperature, and then they were washed twice with RPMI 1640 medium to remove the d-sorbitol. The utilization of blood samples of healthy Japanese volunteers for the parasite culture was approved by the institutional review committee of the Research Institute for Microbial Diseases (RIMD), Osaka University (approval number: 22–3).

Antimalarial activity Ring-form-synchronized parasites were cultured with compounds 1–8 and walsogynes B, D, and E at sequentially decreasing concentrations (50, 15, 5, 1.5, 0.5, and 0.15 µM) for 48 h for the flow cytometric analysis using an automated hematology analyzer, XN-30. The XN-30 analyzer was equipped with a prototype algorithm for cultured falciparum parasites [prototype; software version: 01-03, (build 16)] and used specific reagents (CELLPACK DCL, SULFOLYSER, Lysercell M, and Fluorocell M) (Sysmex, Kobe, Japan) [32, 33]. Approximately 100 µL of the culture suspension diluted with 100 µL phosphate-buffered saline was added to a BD Microtainer MAP Microtube for Automated Process K2 EDTA 1.0 mg tube (Becton Dickinson and Co., Franklin Lakes, NJ, USA) and loaded onto the XN-30 analyzer with an auto-sampler as described in the instrument manual (Sysmex). The parasitemia (MI-RBC%) was automatically reported [32]. Then 0.5% DMSO alone or containing 5 µM artemisinin used as the negative and positive controls, respectively. The growth inhibition (GI) rate was calculated from the MI-RBC% according to the following equation:

The IC50 was calculated from GI (%) using GraphPad Prism version 5.0 (GraphPad Prism Software, San Diego, CA, USA) [34].

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 3421 KB)